Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Development
Brought to you by:
Biotech
Alto's midphase depression trial falls flat
A phase 2b trial of Alto’s lead drug candidate in depression missed its primary and key secondary endpoints, wiping 60% off the biotech’s share price.
Nick Paul Taylor
Oct 23, 2024 4:47am
China-based biotech plans ph. 3 after seeing midstage eye data
Oct 22, 2024 10:37am
Sponsored
Hybrid FSP/FSO Solutions Keep Biotech Trials on Time and on Budget
Nov 1, 2024 8:00am
Merck-Gilead long-acting oral combo suppresses HIV for 48 weeks
Oct 21, 2024 5:06am
Sponsored
Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development?
Oct 2, 2024 8:00am
Supernus links depression drug to fast responses in ph. 2 trial
Oct 18, 2024 9:17am